| 2024-06-13 | Sale | Puma Biotechnology, Inc. PBYI | director | 11,000 0.0222% | $3.37 | $37,096 | -9.94% | |
| 2023-11-29 | Sale | Verve Therapeutics, Inc. VERV | Chief Financial Officer | 554 0.0009% | $11.45 | $6,343 | +4.78% | |
| 2023-06-13 | Sale | Puma Biotechnology, Inc. PBYI | director | 10,000 0.0211% | $3.45 | $34,500 | +10.83% | |
| 2022-11-29 | Sale | Verve Therapeutics, Inc. VERV | Chief Financial Officer | 554 0.0032% | $22.10 | $12,243 | -21.87% | |
| 2021-02-11 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Financial Officer | 6,372 0.0088% | $3.77 | $24,054 | -50% | |
| 2021-01-12 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Financial Officer | 5,884 0.0156% | $8.62 | $50,720 | -53.51% | |
| 2020-01-21 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Financial Officer | 6,256 0.0085% | $6.68 | $41,790 | -16.31% |